神经免疫之峰的攀登者——郝峻巍教授

doi:10.3969/j.issn.1006-7795.2020.05.008

摘要/Abstract

摘要： 郝峻巍教授是国家杰出青年科学基金获得者，国家"万人计划"青年拔尖人才，入选教育部"新世纪优秀人才支持计划"，在神经免疫性疾病的基础及临床转化研究方面均取得了杰出的成就，深耕临床，精于科研，注重转化，体现了新一代首医人勤勉奋斗、开拓创新的精神。

关键词: 神经免疫性疾病, 脑卒中, 神经炎症, 自然杀伤细胞

Abstract: Professor Hao Junwei is the winner of the National Science Fund for Distinguished Young Scholars, the top-notch young talent of the National "Ten Thousand Talents Program", and he was selected into the "New Century Excellent Talents Support Program" of the Ministry of Education. With experienced clinical practice and proficient scientific research, he achieves in the area of immuno-inflammatory and translational medicine of neurological diseases. His diligent, pioneering, and innovative quality represents the enterprising spirit of the new generation of Capital Medical University.

Key words: neuroimmune diseases, stroke, neuroinflammation, natural killer cells

中图分类号:

R503
R74.3

王菲, 刘海杰, 杨佳, 刘峥, 郝峻巍. 神经免疫之峰的攀登者——郝峻巍教授[J]. 首都医科大学学报, 2020, 41(5): 763-767.

Wang Fei, Liu Haijie, Yang Jia, Liu Zheng, Hao Junwei. Climber towards the summit of neuroimmunology——Professor Hao Junwei[J]. Journal of Capital Medical University, 2020, 41(5): 763-767.

参考文献

[1] Hao J W, Liu R L, Piao W H, et al. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology[J]. J Exp Med, 2010, 207(9):1907-1921.
[2] Hao J W, Campagnolo D, Liu R L, et al. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation[J]. Ann Neurol 2011, 69(4):721-734.
[3] Jiang W, Li D J, Han R R, et al. Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophages[J]. Proc Natl Acad Sci U S A, 2017, 114(30):E6202-E6211.
[4] Han B, Li X P, Hao J W. The cholinergic anti-inflammatory pathway:An innovative treatment strategy for neurological diseases[J]. Neurosci Biobehav Rev, 2017, 77:358-368.
[5] Ding Y N, Han R R, Jiang W, et al. Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats[J]. J Immunol, 2016, 197(10):3831-3840.
[6] Jiang W, St-Pierre S, Roy P, et al. Infiltration of CCR2⁺Ly6C^high proinflammatory monocytes and neutrophils into the central nervous system is modulated by nicotinic acetylcholine receptors in a model of multiple sclerosis[J]. J Immunol, 2016, 196(5):2095-2108.
[7] Liu R Q, Ma X F, Chen L, et al. MicroRNA-15b suppresses Th17 differentiation and is associated with pathogenesis of multiple sclerosis by targeting O-GlcNAc transferase[J]. J Immunol, 2017,198(7):2626-2639.
[8] Zhang F, Liu G Y, Li D J, et al. DDIT4 and associated lncDDIT4 modulate Th17 differentiation through the DDIT4/TSC/mTOR pathway[J]. J Immunol, 2018, 200(5):1618-1626.
[9] Dang C, Han B, Li Q, et al. Up-regulation of PGC-1alpha in neurons protects against experimental autoimmune encephalomyelitis[J]. FASEB J, 2019, 33(12):14811-14824.
[10] Li M S, Li Z G, Yao Y, et al. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity[J]. Proc Natl Acad Sci U S A, 2017, 114(3):E396-E405.
[11] Roy-O'Reilly M, McCullough L D. Astrocytes fuel the fire of lymphocyte toxicity after stroke[J]. Proc Natl Acad Sci U S A, 2017, 114(3):425-427.
[12] Han R R, Luo J Y, Shi Y C, et al. PD-L1(programmed death ligand 1) protects against experimental intracerebral hemorrhage-induced brain injury[J]. Stroke, 2017, 48(8):2255-2262.
[13] Li D J, Lang W J, Zhou C, et al. Upregulation of microglial ZEB1 ameliorates brain damage after acute ischemic stroke[J]. Cell Rep, 2018, 22(13):3574-3586.
[14] Han B, Jiang W, Liu H J, et al. Upregulation of neuronal PGC-1alpha ameliorates cognitive impairment induced by chronic cerebral hypoperfusion[J]. Theranostics, 2020, 10(6):2832-2848.
[15] G B D 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2019, 18(5):459-480.